Stuart E. Lind
Impact in
- Cell Biology top 1%
- Cellular Mechanics and Interactions
- Oncology top 2%
- Cancer-related Molecular Pathways
- Metal complexes synthesis and properties
Papers in
-
- Metabolism, Diabetes, and Cancer 5
-
- Trace Elements in Health 7
- Co-authors
- Paul A. Janmey (9 shared papers)Thomas P. Stossel (8 shared papers)Bolin Liu (6 shared papers)Susan M. Edgerton (4 shared papers)Ann D. Thor (4 shared papers)Wei-Qun Ding (11 shared papers)Zeying Fan (3 shared papers)David B. Smith (4 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)New England Journal of Medicine (4 papers)Cell Cycle (4 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Stuart E. Lind
76 papers receiving 5.6k citations
Stuart E. Lind's Hit Papers
Peers
Comparison fields: 5 of 176
- Cell Biology 901
- Oncology 1.2k
- Cancer Research 551
- Immunology and Allergy 214
- Internal Medicine 107
Countries citing papers authored by Stuart E. Lind
This map shows the geographic impact of Stuart E. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Lind more than expected).
Fields of papers citing papers by Stuart E. Lind
This network shows the impact of papers produced by Stuart E. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Lind. The network helps show where Stuart E. Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart E. Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonmuscle Actin-Binding Proteins Hit paper breakdown → | 1985 | 552 |
| 2 | 2009 | 443 | |
| 3 | 1990 | 393 | |
| 4 | 2009 | 345 | |
| 5 | 1977 | 223 | |
| 6 | 2005 | 222 | |
| 7 | Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. | 1988 | 216 |
| 8 | 1993 | 212 | |
| 9 | 1985 | 198 | |
| 10 | 2012 | 184 | |
| 11 | 1988 | 169 | |
| 12 | 1987 | 159 | |
| 13 | 1986 | 142 | |
| 14 | 2011 | 134 | |
| 15 | 1977 | 126 | |
| 16 | 2011 | 124 | |
| 17 | 2009 | 122 | |
| 18 | 1989 | 118 | |
| 19 | 2010 | 117 | |
| 20 | 2008 | 106 |
About Stuart E. Lind
Stuart E. Lind is a scholar working on Molecular Biology, Nutrition and Dietetics, Oncology, Hematology and Cell Biology, having authored 77 papers that have together received 6.0k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), Trace Elements in Health (7 papers), Cellular Mechanics and Interactions (7 papers), Blood properties and coagulation (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers). The work is most often cited by research in Cell Biology (901 citations), Oncology (1.2k citations), Cancer Research (551 citations), Immunology and Allergy (214 citations) and Internal Medicine (107 citations). Stuart E. Lind has collaborated with scholars based in United States, China and France. Frequent co-authors include Paul A. Janmey, Thomas P. Stossel, Bolin Liu, Susan M. Edgerton, Ann D. Thor, Wei-Qun Ding, Zeying Fan, David B. Smith, Byron J. Good and Christine Chaponnier. Their work appears in journals such as Journal of Biological Chemistry, New England Journal of Medicine, Cell Cycle, Journal of Clinical Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.